HTG MOLECULAR DIAGNOSTICS, INC Annual Return On Assets in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Return On Assets history and growth rate from 2015 to 2022.
  • Htg Molecular Diagnostics, Inc Return On Assets for the quarter ending March 31, 2023 was -125 %, a 118% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Return On Assets for 2022 was -105 %, a 113% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Return On Assets for 2021 was -49.4 %, a 9.45% increase from 2020.
  • Htg Molecular Diagnostics, Inc annual Return On Assets for 2020 was -54.5 %, a 18.3% decline from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -105 -55.9 -113% Jan 1, 2022 Dec 31, 2022
2021 -49.4 +5.15 +9.45% Jan 1, 2021 Dec 31, 2021
2020 -54.5 -8.45 -18.3% Jan 1, 2020 Dec 31, 2020
2019 -46.1 -11.6 -33.7% Jan 1, 2019 Dec 31, 2019
2018 -34.5 +74.7 +68.4% Jan 1, 2018 Dec 31, 2018
2017 -109 -17 -18.4% Jan 1, 2017 Dec 31, 2017
2016 -92.1 -31.4 -51.7% Jan 1, 2016 Dec 31, 2016
2015 -60.7 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.